Correlation Between IShares Canadian and Helix BioPharma

Can any of the company-specific risk be diversified away by investing in both IShares Canadian and Helix BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Canadian and Helix BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between iShares Canadian HYBrid and Helix BioPharma Corp, you can compare the effects of market volatilities on IShares Canadian and Helix BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Canadian with a short position of Helix BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Canadian and Helix BioPharma.

Diversification Opportunities for IShares Canadian and Helix BioPharma

-0.25

Correlation Coefficient

IShares Canadian  Helix BioPharma

Very good diversification

The 3 months correlation between IShares and Helix is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding iShares Canadian HYBrid and Helix BioPharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Helix BioPharma Corp and IShares Canadian is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Canadian HYBrid are associated (or correlated) with Helix BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Helix BioPharma Corp has no effect on the direction of IShares Canadian i.e., IShares Canadian and Helix BioPharma go up and down completely randomly.

Pair Corralation between IShares Canadian and Helix BioPharma

Assuming the 90 days trading horizon iShares Canadian HYBrid is expected to generate 0.03 times more return on investment than Helix BioPharma. However, iShares Canadian HYBrid is 29.62 times less risky than Helix BioPharma. It trades about 0.08 of its potential returns per unit of risk. Helix BioPharma Corp is currently generating about 0.0 per unit of risk. If you would invest  1,954  in iShares Canadian HYBrid on September 23, 2024 and sell it today you would earn a total of  30.00  from holding iShares Canadian HYBrid or generate 1.54% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

iShares Canadian HYBrid  vs.  Helix BioPharma Corp

iShares Canadian HYBrid

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in iShares Canadian HYBrid are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy fundamental drivers, IShares Canadian is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Helix BioPharma Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Helix BioPharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Helix BioPharma is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with IShares Canadian and Helix BioPharma

The main advantage of trading using opposite IShares Canadian and Helix BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Canadian position performs unexpectedly, Helix BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Helix BioPharma will offset losses from the drop in Helix BioPharma's long position.

The idea behind iShares Canadian HYBrid and Helix BioPharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.